الفهرس 
ProstaglandinsOnly 14 pages are availabe for public view
 |  | from | 156 |  |  |
| | | from | 156 | | |
Abstract
Introduction: The copper intrauterine devices (IUCDs) are safe, cost-effective in the long term and equally effective compared with tubal sterilization. Aim of the work: The aim of the work is to evaluate the efficacy of the vaginal misoprostol to decrease pain intensity and facilitate IUCD insertion in women who delivered only by cesarean section. Patients and Methods: A double blinded placebo controlled randomized clinical trial. Settings: The study was conducted at Ain Shams University Maternity hospital. Population of the study: 140 women candidate for IUCD insertion were involved in the study. Half of them received 400 microgram of misoprostol (Misotac®) vaginally and the other half received the placebo. Result: Using of misoprostol at a dose of 400 microgram administered vaginally 4-hours prior to IUCD insertion in women who delivered by cesarean section had no effect on the easiness of insertion and did not reduce the incidence of pain during the procedure. Conclusion: The study concluded that using of misoprostol at a dose of 400 microgram administered vaginally 4-hours prior to IUCD insertion in women who delivered by cesarean section had no effect on the easiness of insertion and did not reduce the incidence of pain during the procedure. Recommendations: Upon the results of the study, the following can be recommended: Further studies on a larger scale are needed to explore this issue. No routine use of misoprostol prior to IUCD insertion.